BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castro F, Leite Pereira C, Helena Macedo M, Almeida A, José Silveira M, Dias S, Patrícia Cardoso A, José Oliveira M, Sarmento B. Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screening. Adv Drug Deliv Rev 2021;175:113824. [PMID: 34090966 DOI: 10.1016/j.addr.2021.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Meng Y, Sun J, Zhang G, Yu T, Piao H. The three-dimension preclinical models for ferroptosis monitoring. Front Bioeng Biotechnol 2022;10:1020971. [DOI: 10.3389/fbioe.2022.1020971] [Reference Citation Analysis]
2 Chang M, Dong C, Huang H, Ding L, Feng W, Chen Y. Nanobiomimetic Medicine. Adv Funct Materials. [DOI: 10.1002/adfm.202204791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Satchi-Fainaro R, Florindo HF, Vicent MJ. Clinically-relevant and predictive cancer models for nanomedicine evaluation. Adv Drug Deliv Rev 2022;183:114140. [PMID: 35134434 DOI: 10.1016/j.addr.2022.114140] [Reference Citation Analysis]
4 Baião A, Dias S, Soares AF, Pereira CL, Oliveira C, Sarmento B. Advances in the use of 3D colorectal cancer models for novel drug discovery. Expert Opin Drug Discov 2022;:1-12. [PMID: 35343351 DOI: 10.1080/17460441.2022.2056162] [Reference Citation Analysis]
5 Marques-Magalhães Â, Cruz T, Costa ÂM, Estêvão D, Rios E, Canão PA, Velho S, Carneiro F, Oliveira MJ, Cardoso AP. Decellularized Colorectal Cancer Matrices as Bioactive Scaffolds for Studying Tumor-Stroma Interactions. Cancers (Basel) 2022;14:359. [PMID: 35053521 DOI: 10.3390/cancers14020359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kim MY, Lee H, Ji SY, Kim SY, Hwangbo H, Park SH, Kim GY, Park C, Leem SH, Hong SH, Choi YH. Induction of Apoptosis by Isoalantolactone in Human Hepatocellular Carcinoma Hep3B Cells through Activation of the ROS-Dependent JNK Signaling Pathway. Pharmaceutics 2021;13:1627. [PMID: 34683920 DOI: 10.3390/pharmaceutics13101627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]